Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Protalix BioTherapeutics (PLX) Interest Coverage Ratio (2016 - 2025)

Protalix BioTherapeutics (PLX) has 13 years of Interest Coverage Ratio data on record, last reported at 690.83 in Q1 2025.

  • For Q1 2025, Interest Coverage Ratio fell 5448.29% year-over-year to 690.83; the TTM value through Sep 2025 reached 135.47, up 1477.97%, while the annual FY2024 figure was 3.69, 551.97% up from the prior year.
  • Interest Coverage Ratio reached 690.83 in Q1 2025 per PLX's latest filing, down from 175.83 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 175.83 in Q4 2024 and bottomed at 690.83 in Q1 2025.
  • Average Interest Coverage Ratio over 5 years is 32.17, with a median of 3.84 recorded in 2022.
  • Peak YoY movement for Interest Coverage Ratio: skyrocketed 1043.44% in 2024, then crashed 5448.29% in 2025.
  • A 5-year view of Interest Coverage Ratio shows it stood at 9.87 in 2021, then crashed by 138.88% to 3.84 in 2022, then crashed by 385.54% to 18.64 in 2023, then surged by 1043.44% to 175.83 in 2024, then crashed by 492.9% to 690.83 in 2025.
  • Per Business Quant database, its latest 3 readings for Interest Coverage Ratio were 690.83 in Q1 2025, 175.83 in Q4 2024, and 15.35 in Q3 2024.